The utility of neutrophil-to-lymphocyte ratio determined at initial diagnosis in predicting disease stage and discriminating between active and stable disease in patients with sarcoidosis: a cross-sectional study

References

• Grunewald J, Grutters JC, Arkema EV, et al. Sarcoidosis. Nat Rev Dis Primers. 2019 Jul 4;5(1):45.
   PubMed Web of Science ®Google Scholar
• Kiter G, Musellım, B, Cetınkaya, E, et al. Clinical presentations and diagnostic work-up in sarcoidosis: a series of Turkish cases (clinics and diagnosis of sarcoidosis). Tuberk Toraks. 2011;59(3):248–258.
   PubMedGoogle Scholar
• Gurrieri C, Bortoli M, Brunetta E, et al. Cytokines, chemokines and other biomolecular markers in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(1):9–14.
   Google Scholar
• Ahmadzai H, Loke WSJ, Huang S, et al. Biomarkers in sarcoidosis: a review. Current Biomarker Findings. 2014;4 93–106.
   Google Scholar
• Januzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–2165.
   PubMed Web of Science ®Google Scholar
• Korkmaz C, Demircioglu S. The association of neutrophil/lymphocyte and platelet/lymphocyte ratios and hematological parameters with diagnosis, stages, extrapulmonary involvement, pulmonary hypertension, response to treatment, and prognosis in patients with sarcoidosis. Can Respir J. 2020;2020:1696450. Sep 24.
   PubMed Web of Science ®Google Scholar
• Ocal N, Dogan D, Ocal R, et al. Effects of radiological extent on neutrophil/lymphocyte ratio in pulmonary sarcoidosis. Eur Rev Med Pharmacol Sci. 2016;20(4):709–714.
   PubMed Web of Science ®Google Scholar
• Silva PH, Parra ER, Zocolaro WS, et al. Immunophenotyping and extracellular matrix remodeling in pulmonary and extrapulmonary sarcoidosis. J Bras Pneumol. 2012 May-Jun;38(3):321–330.
   PubMed Web of Science ®Google Scholar
• Casanova N, Zhou T, Knox KS, et al. Identifying novel biomarkers in sarcoidosis using genome-based approaches. Clin Chest Med. 2015 Dec;36(4):621–630.
   PubMed Web of Science ®Google Scholar
• Dirican N, Anar C, Kaya S, et al. The clinical significance of hematologic parameters in patients with sarcoidosis. Clin Respir J. 2016 Jan;10(1):32–39.
   PubMed Web of Science ®Google Scholar
• Mirsaeidi M, Mortaz E, Omar HR, et al. Association of neutrophil to lymphocyte ratio and pulmonary hypertension in sarcoidosis patients. Tanaffos. 2016;15(1):44–47.
   PubMedGoogle Scholar
• Demirkol S, Balta S, Kucuk U, et al. The neutrophil lymphocyte ratio may be useful inflammatory indicator before applying other expensive and invasive procedures. Indian J Ophthalmol. 2013 Nov;61(11):685.
   PubMed Web of Science ®Google Scholar
• Sørensen AK, Holmgaard DB, Mygind LH, et al. Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study. J Inflamm (Lond). 2015 Mar 18;12(1):20.
   PubMed Web of Science ®Google Scholar
• Faria SS, Fernandes PC Jr, Silva MJ, et al. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 2016 Dec 12;10:702.
   PubMed Web of Science ®Google Scholar
• Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573–577.
   PubMed Web of Science ®Google Scholar
• Iliaz S, Iliaz R, Ortakoylu G, et al. Value of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis. Ann Thorac Med. 2014 Oct;9(4):232–235.
   PubMed Web of Science ®Google Scholar
• Yalnız E, Karadeniz G, Üçsular FD, et al. Predictive value of platelet-to-lymphocyte ratio in patients with sarcoidosis. Biomark Med. 2019 Feb;13(3):197–204.
   PubMed Web of Science ®Google Scholar
• Üçsular F, Polat G, Karadeniz G, et al. Predictive value of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hypersensitivity pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020012.
   PubMed Web of Science ®Google Scholar
• Gungor S, Akturk UA, Yalcinsoy M, et al. What is the neutrophil/lymphocyte ratio in sarcoidosis? Bratisl Lek Listy. 2016;117(3):152–155.
   PubMed Web of Science ®Google Scholar
• Kemal CT, Aylin OA, Volkan K, et al. The importance of PET/CT findings and hematological parameters in prediction of progression in sarcoidosis cases. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(3):242–250.
   PubMed Web of Science ®Google Scholar
• Aldemir M, Baki ED, Adali F, et al. Comparison of neutrophil: lymphocyte ratios following coronary artery bypass surgery with or without cardiopulmonary bypass. Cardiovasc J Afr. 2015;23:1–6.
   Google Scholar
• Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460.
   PubMed Web of Science ®Google Scholar
• Yurtdaş M, Yaylali YT, Aladağ N, et al. Heart rate recovery after exercise and its relation with neutrophil-to-lymphocyte ratio in patients with cardiac syndrome X. Coron Artery Dis. 2014;25(6):485–492.
   PubMed Web of Science ®Google Scholar
• Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 patients after 5 years’ observations. Br Med J. 1961;2(5261):1165–1172.
   PubMed Web of Science ®Google Scholar
• Panselinas E, Halstead L, Schlosser RJ, et al. Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement. South Med J. 2010 Sep;103(9):870–875.
   PubMed Web of Science ®Google Scholar
• Ding K, Xu ZJ, Huang H, et al. Analysis of the treatment and prognosis of 59 patients with sarcoidosis. Zhonghua Nei Ke Za Zhi. 2007 Jan;46(1):52–55.
   PubMedGoogle Scholar
• D’alessandro M, Bergantini L, Carleo A, et al. Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? Minerva Med. 2020 May 14. Epub ahead of print. PMID: 32407050. DOI:10.23736/S0026-4806.20.06614-8.
   Web of Science ®Google Scholar
• Vasakova M, Morell F, Walsh S, et al. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017 Sep 15;196(6):680–689.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Chubachi S, Irie H, et al. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients. BMC Pulm Med. 2018 May 2;18(1):65.
   PubMed Web of Science ®Google Scholar
• Phan T, Brailovsky Y, Fareed J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict all-cause mortality in acute pulmonary embolism. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029619900549.
   Web of Science ®Google Scholar
• Ozsu S, Ozcelik N, Oztuna F, et al. Prognostic value of red cell distribution width in patients with sarcoidosis. Clin Respir J. 2015 Jan;9(1):34–38.
   PubMed Web of Science ®Google Scholar